The Effects of a 6-week Balance, Agility, Strengthening Exercise Class
The Effects of a 6-week Balance, Agility, Strengthening Exercise (BASE) Class on Balance Performance, Self-Efficacy, and Fear of Falling in Cancer Survivors
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Objectives Given that this combination of outcomes have not been sufficiently measured in the cancer population, and most balance and agility training programs are 12 weeks or more in length, the objectives of this study is to determine the effects of a 6-week intervention, the Balance, Agility, Strengthening Exercise (BASE) Class, on the balance performance, self-efficacy, and the fear of falling in cancer survivors.
Methods This study is a 3 year exercise interventional study, with 20 participants per year. In year one of the study, 20 participants will be enrolled in a 6-week Balance, Agility, Strengthening Exercise (BASE) Class. The pre-program data collection will include: demographic data; initial intake examination utilizing standard physiotherapy assessment of range of motion, flexibility, and strength; use of validated balance performance tools; and validated self-report surveys for balance confidence, fear of falling, and quality of life. The participants will attend the BASE class twice weekly for 6-weeks. The post-program data collection is to include the same outcome measures.
Subsequent years will be an observational study of the same design, enrolling 20 participants in year 2 and 3 for a 6-week BASE class. A total of 60 participants will be recruited over 3 years providing adequate power to assess program efficacy. Based on the resources available, this study can only accommodate 20 participants per year and can only be conducted for a 6-week period each year of the study.
Participants and recruitment Posters and hand bills will be distributed and placed throughout CancerCare recruiting participants for the study (self-referral). In addition, hand bills will provided for oncologists, oncology nurses, and psychosocial clinicians to give to patients/potential participants within the clinical areas at CancerCare. After receiving the hand bill with the study description and information, potential participants can choose to phone or e-mail the PI to indicate their interest in the study. A phone interaction will take place between the PI and potential participant to determine if they meet the inclusion criteria. Once it is determined that they meet the inclusion criteria, an in-person meeting will be arranged and they will be provided with the study's objectives, risks and benefits, and the consent document. Time will be allowed for the potential participant to ask questions and to consider their enrollment in the study. After a thorough discussion and review of the documents, the potential participant will be asked to sign the consent form. If requested, a person will be allowed to take the consent form home for further consideration prior to signing.
Data collection Prior to the start of the BASE Class, an initial assessment will take place. This assessment will utilize standard physiotherapy assessment of range of motion, flexibility, and strength; use of validated balance performance tools; and validated self-report surveys for balance confidence, fear of falling, and quality of life.
Intervention:
The BASE class will run twice weekly for 1.5 hours each session over a 6-week period and will include a 10-minute warm-up, 30 minutes of static and dynamic balance exercises, 20 minutes of lower extremity strengthening exercises, and a 10-minute cool-down. There will be weekly falls prevention and mobility enhancement education provided during the class.
Statistical Analysis Pre-post paired comparisons will be conducted for each balance performance and self-reported questionnaire measure. A paired T-test or Wilcoxon signed ranks test will be performed according to the observed distributions.
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Karen Dobbin, MSc
- Telefonnummer: 12042289361
- E-Mail: kdobbin@cancercare.mb.ca
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- community-dwelling
- ambulatory
- diagnosed with hematological or solid cancer tumors (except brain tumors/brain metastases)
- age >18 years
- self-identified as experiencing impaired balance, and scoring less than 80% on the Activities-specific Balance Confidence Scale
- able to communicate in English
Exclusion Criteria:
- metastatic cancer
- those unable to provide informed consent
- those having previously received physiotherapy and exercise instruction from the principal investigator.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Interventional
Balance, Agility, Strengthening Exercise (BASE) class intervention - a 6-week exercise class to determine the change in balance performance, fear of falling and self-efficacy
|
The BASE class will be conducted twice weekly for 1.5 hours each session over a 6-week period and will include a 10-minute warm-up, 30 minutes of static and dynamic balance exercises, 20 minutes of lower extremity strengthening exercises, and a 10-minute cool-down.
There will be weekly falls prevention and mobility enhancement education provided during the class.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Balance Performance - miniBest
Zeitfenster: 1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
Mini-Balance Evaluation Systems Test is a 14-item balance scale covering a broad spectrum of performance tasks including dynamic body stability, transfers, gait, variation of support surfaces, and of visual conditions, obstacle negotiation, reactions to external forces and performance during dual-tasking.
|
1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
|
Balance Performane - TUG
Zeitfenster: 1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
Timed Up and Go: a rise from a chair, 3-meter walk, turn and walk back to chair and sitting.
Designed to measure mobility, balance, and locomotor performance; evaluates falls risk and basic functional mobility.
|
1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
|
Balance Performance - Timed Unipedal Stance Test
Zeitfenster: 1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
A simple test for measuring static aspects of balance ability, measured in seconds with eyes open and eyes closed; useful when combined with other balance performance tests.
|
1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
|
Balance Performance - 6-meter Gait Speed Test
Zeitfenster: 1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
A 6-meter walking test measured in meters/second; an indicator of walking ability, function, and mobility.
|
1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
|
Balance Performance - Four Square Step Test
Zeitfenster: 1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
A timed measurement of stepping whilst changing direction to provide a measure of dynamic standing balance and mobility; stepping forwards, sideways, and backwards over obstacles in a specified sequence.
|
1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Self-report ABC Scale
Zeitfenster: 1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
Activities-specific Balance Confidence Scale is a 16-item self-report questionnaire examining a person's confidence in a broad range of activities with various difficulties; to assess balance confidence in ambulatory community-dwelling older adults
|
1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
|
Self-report MFES
Zeitfenster: 1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
Modified Fall Efficacy Scale International is a 15 question self-rated scale assessing a person's confidence in performing activities in the home, plus additional items related to outdoor activities.
|
1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
|
self-report Fear of Falling
Zeitfenster: 1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
A 14 item scale that examines fear of falling and the effect it has on participation in various activities
|
1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
|
Self-report Quality of Life FACT-G
Zeitfenster: 1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
Functional Assessment of Cancer Therapy - General is a 27-item self-report instrument that consists of 4 sub-scales: physical well-being, social well-being, emotional well-being, and functional well-being to measure quality of life for cancer patients.
|
1-2 weeks prior to BASE Class, change from baseline 1-2 weeks post BASE Class
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Voraussichtlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- H2019:470
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Neubildungen
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Celgene... und andere MitarbeiterAbgeschlossenIDH2-Mutation | Accelerated/Blast-phase Myeloproliferative Neoplasm | Myelofibrose in der chronischen PhaseVereinigte Staaten, Kanada